DeLondra Oncology provides pharmaceutical medicine consultancy services in oncology early clinical development to both large pharmaceutical companies and oncology biotech companies in Europe, North America and Asia.
The company is based in Cheshire in the UK.
Planning
We work in close collaboration with our clients in the design and planning of their early clinical development programmes
Execution
We focus on delivery of high quality consulting to our clients
Quality
We focus on delivering quality consultancy work, which delivers effective results for our clients.
Services We Provide
DeLondra Oncology provides a range of consultancy services to clients
Clinical Advisory Services
DLO provides strategic services in the following areas in early oncology clinical development:
Candidate selection to First-time in humans studies
Clinical trial strategy development
Targeted therapy combination strategy development
Radiation therapy combination strategy development
Immunotherapy combination strategy development
Clinical Study Design Services
DLO can provide consulting advice on different study designs:
Accelerated study design
Platform study design
Translational science programme integration
Additional services
DLO can provide strategic advice on clinical study analytics, particularly Phase IA/B, Phase IIA studies in early development
